JDD Multimedia

Best Practices & Practical Pearls for Safely Reopening Derm Practices

The Journal of Drugs in Dermatology (JDD)  is proud to present an essential education program on the topic of guidelines for safely reopening dermatology practices during the COVID-19 pandemic, lead by Dr. Jeffrey S. Dover, Director of SkinCare Physicians in Chestnut Hill, Massachusetts and a panel of dermatology thought leaders.

This video series was produced by the Journal of Drugs in Dermatology and supported in part by Alastin Skincare, Endo Aesthetics. Ortho Dermatologics, and Sciton.

Supported in part by

Best Practices & Practical Pearls for Safely Reopening Derm Practices

Featuring Dr. Jeffrey S. Dover

Discussion Topics

  • Medical Office Preparedness
  • Managing the Office Environment
  • General Guidance
  • Cleaning & Disinfecting Practices
  • Practices
  • PPE and Medical Supplies

Best Practices & Practical Pearls for Safely Reopening Derm Practices

Featuring Dr. Kavita Mariwalla

Discussion Topics

  • Clinical and Non-Surgical Treatment
  • Related Guidance
  • Treatment room set up
  • Anesthesia and analgesia
  • Injectables

Best Practices & Practical Pearls for Safely Reopening Derm Practices

Featuring Dr. Thomas E. Rohrer

Discussion Topics

  • Surgical Treatment
  • Related Guidance
  • Treatment room set up
  • Post-Surgery Follow Up

Best Practices & Practical Pearls for Safely Reopening Derm Practices

Featuring Dr. Terrence Keaney

Discussion Topics

  • Non-invasive body contouring
  • Energy-based procedures of the face and neck
  • Skin treatment procedures

Best Practices & Practical Pearls for Safely Reopening Derm Practices

Featuring Dr. Nazanin Saedi

Discussion Topics

  • Employee health and training
  • Recognition of symptoms
  • Symptomatic patients and employees
  • Office arrival, check-in and check-out
  • Pre-screening patients

You May Also Like

The Role of Colloidal Oatmeal in Managing Eczema and Beyond

| JDD Highlights, JDD Webinars, Oats, The Latest | No Comments
Sponsored by This webinar highlights the data supporting the mechanism of action of oat in emollients as well as clinical efficacy and safety of its use in atopic dermatitis and…

ANNOUNCEMENT: WebMD Acquires SanovaWorks

| JDD Highlights, JDD in the Media, The Latest | No Comments
NEW YORK, Jan. 25, 2022 /PRNewswire/ -- WebMD Health Corp., an Internet Brands company and a leader in health information services for physicians, other healthcare professionals and consumers, today announced that it…

JDD in the News: Medical Cannabis Products, S. aureus-Based Product for AD

| Atopic Dermatitis, COVID 19, JDD Highlights, JDD in the Media, Psoriasis, The Latest | No Comments
By Allison Sit Practical Dermatology published an article, “Survey: Consumers Interested in Medical Cannabis Products for Inflammatory Skin Disorders,” about the January JDD study, “Consumer Perspectives on and Utilization of…